-
Dual HER2–VEGFR2 Targeting in TNBC Metastasis
2026-09-01
The reference study evaluates lapatinib plus Telatinib (BAY 57-9352) in HER2-negative MDA-MB-231 triple-negative breast cancer cells, focusing on proliferation, invadopodia formation, and angiogenic tube formation. Its main contribution is a phenotype-centered preclinical framework for testing coordinated HER2/VEGFR2 pathway inhibition, while the in vitro design does not establish molecular target engagement, pharmacological synergy, or clinical efficacy.
-
Nonselective β-Blockade Delays HCT Engraftment
2026-09-01
Nishino and colleagues show that nonselective β-adrenergic blockade, exemplified by carvedilol, can impair hematopoietic regeneration after allogeneic hematopoietic cell transplantation, whereas β1-selective blockade has substantially less effect. By combining mouse transplantation experiments with human cohort analyses, the study identifies β-receptor selectivity, transplant setting, posttransplant chemotherapy, and graft cell dose as clinically relevant determinants of engraftment.
-
Hyperthermia–Cisplatin Activates Caspase-8
2026-08-31
A 2024 study shows that hyperthermia strengthens cisplatin-induced cancer-cell death by promoting Cullin 3-associated K63-linked polyubiquitination, accumulation, and activation of caspase-8. The resulting pathway links caspase-3-mediated apoptosis with gasdermin-associated pyroptosis and provides a mechanistic framework for interpreting combination-therapy responses.
-
Grazoprevir/Elbasvir Therapy for HCV: Evidence Review
2026-08-31
The reference review explains why combining the NS3/4A protease inhibitor grazoprevir with the NS5A inhibitor elbasvir created a compact, interferon-free strategy for HCV treatment. Its synthesis emphasizes high sustained virologic response rates, activity in difficult-to-treat populations, resistance-aware treatment selection, and the importance of interpreting trial and real-world evidence separately.
-
Bufuralol hydrochloride in Organoid PK Workflows
2026-08-30
Bufuralol hydrochloride combines broad β-adrenoceptor blockade with partial intrinsic sympathomimetic activity, making it useful for separating receptor effects from exposure and metabolism. When paired with human iPSC-derived intestinal organoids, it supports a more human-relevant workflow for cardiovascular pharmacology research and translational pharmacokinetic studies.
-
TAI-1 Hec1 Inhibitor: Assays and Workflows
2026-08-29
TAI-1 enables mechanism-led studies of Hec1 disruption, chromosome misalignment, and apoptotic cell death across cancer models. This guide translates its reported potency and combination activity into practical dose-response, microscopy, genotype, and troubleshooting workflows while separating direct evidence from exploratory assay design.
-
KPT-330 (Selinexor): From Nuclear Export to Translation
2026-08-28
A translational framework for using KPT-330 (Selinexor) to connect CRM1 biology with biomarker strategy, combination design, and reproducible oncology workflows.
-
MK-0812 Workflow for MASH Inflammation
2026-08-28
Use MK-0812 as a mechanistic probe for CCR2-dependent monocyte trafficking in gut–liver inflammation research. Its whole-blood potency, mouse pharmacology, and DMSO solubility support workflows that connect immune-cell recruitment with intestinal TM6SF2, microbiota, and MASH phenotypes.
-
S Tag Peptide (A6007): Practical Workflow Guide
2026-08-27
S Tag Peptide (SKU A6007) is a soluble 15-amino-acid tag for recombinant protein detection, antibody-based purification, and protein solubility improvement. It is best used in aqueous workflows or genetically encoded fusions and should not be treated as a standalone RNase reagent or stored as an ethanol-based solution.
-
Tadalafil-Primed MSC Exosomes in Pulmonary Hypertension
2026-08-27
The reference study shows that tadalafil pretreatment changes the therapeutic activity of mesenchymal stem cell-derived exosomes in pulmonary hypertension. Its central mechanistic contribution is a CREB1–miR-29a-3p–ENPP2 axis that connects exosome-mediated anti-inflammatory effects with reduced vascular remodeling, while also identifying experimental opportunities for more precise proliferation analysis.
-
Brassinolide Workflows for Plant and Translational Research
2026-08-26
Brassinolide supports a distinctive cross-domain workflow: benchmark plant growth activity with rice lamina inclination assays, then investigate apoptosis and metabolic endpoints with formulation-aware mammalian experiments. This guide connects practical handling, assay controls, structure–activity insights, and troubleshooting for more reproducible cancer research and diabetes research.
-
MOG (35-55) for EAE Research Workflows
2026-08-26
MOG (35-55) is a practical myelin oligodendrocyte glycoprotein peptide for building reproducible autoimmune encephalomyelitis models and connecting neurological phenotypes with immune and molecular readouts. This guide emphasizes preparation, dose selection, assay design, PARP7–STAT1/2 interpretation, and troubleshooting rather than peptide description alone.
-
Z-WEHD-FMK: A Translational View of Pyroptosis
2026-08-25
Caspase-1 is more than a terminal pyroptosis effector: it can function as a transcriptionally controlled switch linking tumor cell fate, inflammation, and pathogen biology. This article explains how Z-WEHD-FMK, also known as Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK, can help translational researchers distinguish caspase dependence from upstream pathway architecture while designing more rigorous inflammation, cancer, and infectious disease studies.
-
S Tag Peptide: Practical Fusion-Tag Guide
2026-08-25
S Tag Peptide is a compact, highly soluble fusion tag for recombinant protein detection, antibody-based capture, and protein solubility improvement. It is suitable for N- or C-terminal genetic fusions, but it should not be treated as an independently folded enzyme, a universal solubility solution, or an ethanol-compatible reagent.
-
Lipid Composition Shapes mRNA Lipoplex Immunity
2026-08-24
The 2024 reference study systematically examined how cationic and neutral lipid selection changes the performance of systemically administered mRNA lipoplexes in mice. Its findings identify DC-1-16 or DDAB combined with DOPE and PEG-Chol as promising compositions for antibody induction and luciferase expression in the spleen and lungs, while also showing why formulation composition must be evaluated experimentally rather than inferred from lipid charge alone.